Patents by Inventor Maria Paz RUIZ BLAS

Maria Paz RUIZ BLAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTIFUNCTIONAL NANOPARTICLES FOR THERAGNOSIS
    Publication number: 20230248847
    Abstract: The present invention relates to the field of medicine, particularly to functionalised nanoparticles (NP) for use in cancer therapy (treatment or diagnosis), to pharmaceutical compositions or nano devices comprising same, and also to a method for obtaining said functionalised nanoparticles. The nanoparticles described in the present invention can be used specifically to treat cancer efficiently, as same can selectively detect tumour cells.
    Type: Application
    Filed: October 6, 2022
    Publication date: August 10, 2023
    Inventors: Rosario María SÁNCHEZ MARTÍN, Juan Antonio MARCHAL CORRALES, Juan José DÍAZ MOCHÓN, Victoria CANO CORTÉS, Saúl Abenhamar NAVARRO MARCHAL, Maria Paz RUIZ BLAS
  • MULTIFUNCTIONAL NANOPARTICLES FOR THERAGNOSIS
    Publication number: 20210162077
    Abstract: The present invention relates to the field of medicine, particularly to functionalised nanoparticles (NP) for use in cancer therapy (treatment or diagnosis), to pharmaceutical compositions or nano devices comprising same, and also to a method for obtaining said functionalised nanoparticles. The nanoparticles described in the present invention can be used specifically to treat cancer efficiently, as same can selectively detect tumour cells.
    Type: Application
    Filed: April 12, 2019
    Publication date: June 3, 2021
    Inventors: Rosario María SÁNCHEZ MARTÍN, Juan Antonio MARCHAL CORRALES, Juan José DÍAZ MOCHÓN, Victoria CANO CORTÉS, Saúl Abenhamar NAVARRO MARCHAL, Maria Paz RUIZ BLAS
  • METHOD FOR THE DETECTION OF CIRCULATING TUMOUR CELLS, BOTH CIRCULATING TUMOUR CELLS OF THE EPITHELIAL PHENOTYPE AND CIRCULATING TUMOUR CELLS HAVING EPITHELIAL-MESENCHYMAL TRANSITION (EMT) MARKERS, USING THE MIRNA-21 AS A BIOMARKER
    Publication number: 20170321261
    Abstract: The present invention provides an in vitro method of detecting circulating tumour cells, circulating tumour cells of epithelial phenotype and circulating tumour cells of epithelial to mesenchymal transition (EMTs), in a biological sample using, as an indicator, expression levels of miRNA-21, and obtaining a result of the method by comparing the expression levels of said miRNA-21 with a negative control or with a positive control, wherein if the expression levels in the cells of the biological sample are over-expressed in comparison to a negative control is indicative of the presence of circulating tumour cells in said biological sample or wherein if the expression levels in the cells of the biological sample are expressed in an amount greater than ? of the maximum expression achieved in a positive control is indicative of the presence of circulating tumour cells in said biological sample.
    Type: Application
    Filed: September 18, 2015
    Publication date: November 9, 2017
    Inventors: María José SERRANO FERNÁNDEZ, Juan José DÍAZ MOCHÓN, Francisco GABRIEL ORTEGA, José Antonio LORENTE ACOSTA, José Luis GARCÍA PUCHE, Maria Paz RUIZ BLAS, Rosario María SÁNCHEZ MARTÍN